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Background: The prevalence of obesity has dramatically increased worldwide and has attracted rising attention,
but the mechanism is still unclear. Previous studies revealed that transient receptor potential vanilloid 1 (TRPV1)
channels take part in weight loss by enhancing intracellular Ca2+ levels. However, the potential mechanism of the
effect of dietary capsaicin on obesity is not completely understood. Ca2+ transfer induced by connexin43 (Cx43)
molecules between coupled cells takes part in adipocyte differentiation. Whether TRPV1-evoked alterations in
Cx43-mediated adipocyte-to-adipocyte communication play a role in obesity is unknown.
Materials and methods: We investigated whether Cx43 participated in TRPV1-mediated adipocyte lipolysis in
cultured 3T3-L1 preadipocytes and visceral adipose tissues from humans and wild-type (WT) and TRPV1-deficient
(TRPV1-/-) mice.
Results: TRPV1 and Cx43 co-expressed in mesenteric adipose tissue. TRPV1 activation by capsaicin increased the
influx of Ca2+ in 3T3-L1 preadipocytes and promoted cell lipolysis, as shown by Oil-red O staining. These effects
were deficient when capsazepine, a TRPV1 antagonist, and 18 alpha-glycyrrhetinic acid (18α-GA), a gap-junction
inhibitor, were administered. Long-term chronic dietary capsaicin reduced the weights of perirenal, mesenteric and
testicular adipose tissues in WT mice fed a high-fat diet. Capsaicin increased the expression levels of p-CaM, Cx43,
CaMKII, PPARδ and HSL in mesenteric adipose tissues from WT mice fed a high-fat diet, db/db mice, as well as
obese humans, but these effects of capsaicin were absent in TRPV1-/- mice. Long-term chronic dietary capsaicin
decreased the body weights and serum lipids of WT mice, but not TRPV1-/- mice, fed a high-fat diet.
Conclusion: This study demonstrated that capsaicin activation of TRPV1-evoked increased Ca2+ influx in Cx43-mediated
adipocyte-to-adipocyte communication promotes lipolysis in both vitro and vivo. TRPV1 activation by dietary capsaicin
improves visceral fat remodeling through the up-regulation of Cx43.
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Obesity is the result of sustained mismatches that favor
caloric intake over caloric expenditure. The prevalence of
obesity during the last few years has dramatically increased
worldwide [1]. In addition to many other disorders, obesity
greatly increases the risk of developing a metabolic* Correspondence: zhuzm@yahoo.com; zhenchengyan@sina.com
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unless otherwise stated.syndrome and is associated with decreased life expectancy
and increased health costs [2]. For these reasons, obesity
has attracted increasing attention across multiple scientific
disciplines. Although the adipose tissue of obese animals
and humans is increased at both subcutaneous and visceral
sites, visceral fat is responsible for the metabolic conse-
quences of obesity [3]. The reasons for this effect are
unclear. Visceral fat mass is closely related to the metabolic
consequences of obesity; visceral adipose tissue depots are
key correlates of the metabolic abnormalities associated
with being overweight/obese, including inflammation. Thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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stimulate the proinflammatory state that characterizes
obesity. The increased secretion of prothrombin activator
inhibitor-1 from fat cells may play a role in the procoagu-
lant state of obesity and, along with changes in endothelial
function, may be responsible for the increased risk of
cardiovascular disease and hypertension [4-6].
Capsaicin, the major pungent ingredient in hot peppers,
is a potent agonist for the transient receptor potential
vanilloid 1 (TRPV1) channel, also called the capsaicin
receptor. TRPV1 is a non-selective cation channel with a
preference for cations; it transduces signals for the sensa-
tions of noxious heat and pain [7]. TRPV1 is highly
expressed in sensory neurons and in vasculature, adipose,
and liver tissues [8-10]. The earlier studies from human
showed an increase in diet-induced-thermogenesis and
lipid oxidation when high fat diet with capsaicin [11,12].
But studies of TRPV1 in weight loss present mixed results
and the controversies. Marshall N J, et al, their results do
not support the concept that TRPV1 plays a major role in
influencing weight gain [13]. Gram DX, et al found that
capsaicin had no effect on Zucker diabetic fatty (ZDF)
animals weight loss, and the terminal body weight of
the capsaicin-treated rats was significantly higher than
that of the vehicle-treated ones [14]. An increase in energy
expenditure after capsaicin in take was supported by stud-
ies by various investigators [15-17]. Some studies revealed
a role for TRPV1 in promoting fat accumulation and
weight gain because long-term TRPV1 antagonists or
agonists administration can promote TRPV1 desensiti-
zation [18,19]. Our previous studies detected TRPV1
channels in 3T3-L1-preadipocytes and visceral adipose
tissue from mice and humans. Activation of TRPV1
channels by capsaicin prevented adipogenesis and obesity
[20] and nonalcoholic fatty liver disease [21]. However,
the potential mechanism of the effect of dietary capsa-
icin on visceral fat accumulation and remodeling is not
completely understood.
Gap-junctional communication (GJC) plays critical roles
in cell growth and differentiation. Gap junctions allow the
transfer of ions and small molecules between coupled cells
and enable individual cells to communicate with their
neighbors and match the immediate needs of coupled cells
within a cluster [22]. The major component of gap
junctions is connexin43 (Cx43), which exists in almost all
tissues and in 3T3-L1 cells; this molecule allows for cell-
to-cell communication. Intracellular Ca2+ is one of the
important signals in adipogenesis and regulates Cx43
function in adipocytes. The expression of Cx43 is down-
regulated at the transcriptional level during adipogenesis
in the H-1/A cell line, a marrow stromal cell line that dif-
ferentiates into adipocytes [23]. More recently, Yanagiya
et al. reported that functional gap junctions are required
for progression through a specific early stage of the 3T3-L1 preadipocyte differentiation program. However, the
role of Cx43 is different during the later stages of adipo-
genesis, particularly during adipocyte maturation. Inhibit-
ing Cx43 degradation or constitutively over-expressing
Cx43 blocks adipocyte differentiation via increases in
intracellular ATP and [Ca2+] [24,25]. Therefore, GJC plays
some important roles in adipocyte differentiation and lipid
metabolism. TRPV1-evoked alterations in Cx43-mediated
adipocyte-to-adipocyte communication play an important
role in obesity. Here, we show that the activation of
TRPV1 by dietary capsaicin affects visceral fat accumula-
tion and remodeling through a Cx43-mediated cell-to-cell
intracellular [Ca2+] increase.
Materials and methods
Animal treatment and experimental procedures
All mice (C57BL/6 WT mice, TRPV1-/- mice and db/db
mice) were purchased from Jackson Laboratory (Bar
Harbor, Maine, USA). TRPV1-/- mice which TRPV1 gene
was knocked out in the whole body, not conditioned
knockout we used in the experiments. WT and TRPV1-/-
male mice were randomized into three groups respectively
(n = 15, 5 mice/cage) at 4-6 weeks of age, one group
received standard laboratory chow, one group received
high-fat diet, one group received high-fat diet plus 0.01%
capsaicin. The high-fat diet supplied 49% of the calories as
fat and 30% of the calories as carbohydrate. Db/db male
mice were randomized into two groups respectively (n = 6,
6 mice/cage) at 4-6 weeks of age, one group received
standard laboratory chow, the other group received stand-
ard laboratory chow plus 0.01% capsaicin. The standard
laboratory chow diet provided 10% of the calories as fat
and 68% as carbohydrate. All mice were housed in colony
cages with a 12-hour light/12-hour dark cycle with free
access to food and water for 5 months, body weight was
measured every two weeks. At the end of 5 months, blood
glucose was measured. Visceral fat was removed and
weighted. Serum lipids were analyzed using routine tech-
niques. All of the experiment procedures were performed
in accordance with protocols approved by the Institutional
Animal Care and Research Advisory Committee.
Subjects Characteristics
We recruited the obese male subjects and those were clas-
sified if waist circumference was more than 90 cm accord-
ing to the Asian criteria of WHO Regional Office for the
Western Pacific/International Association for the Study of
Obesity/International Obesity Task Force. Age, body mass
index, waist circumference were obtained. Visceral fat tis-
sues were obtained from patients during regular scheduled
cholecystectomy. Cholecystectomy had to be performed
because of symptomatic gallstones. The protocol was ap-
proved by the local Ethics Committee. All subjects gave
written informed consent.
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The adipose tissue was cleaned with saline and weighted.
Visceral fats from WT mice and human were observed
with frost slice techniques and stained with anti-TRPV1
or Cx43 antibodies [20]. The TRPV1 and Cx43 in isolated
3T3-L1 preadipocytes or adipocytes primary cultured
from visceral adipose tissue were identified by immu-
nofluorescence stain. 3T3-L1 preadipocytes were cul-
tured, fixed, and stained with the lipophilic dye oil-red
O (Sigma-Aldrich). Red staining showed lipid droplets
in the cytoplasm, indicating the number of lipid drop-
lets in 3T3-L1 preadipocytes according to established
techniques [26].Cell culture and adipocyte differentiation assay
Murine 3T3-L1 preadipocytes were cultured and main-
tained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum (Hyclone) containing
100 μg/ml penicillin and 100 μg/ml streptomycin (GIBCO).
Cells were plated and grown until 2 days post-confluence.
Differentiation was then induced (day 0) by changing the
medium to Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum, 0.5 mmol/L 3-isobutyl-
1-methylxanthine, 1 μmol/L dexarmethasone, and 10 μg/
ml insulin (Sigma-Aldrich). After 2 days the medium was
replaced with the medium containing only 10 μg/ml insulin
[27]. To confirm the functional properties of TRPV1 chan-
nels and Cx43 gap-junction on adipogenesis of 3T3-L1 pre-
adipocytes, on the 8th day after differentiation, the TRPV1
agonist capsaicin (1 μmol/L), or TRPV1 antagonist capsaze-
pine (1 μmol/L), or inhibitor of Cx43 gap-junction 18
alpha-glycyrrhetinic acid (18α-GA, 150 μmol/L), (Sigma-
Aldrich) were added to the medium for 24 hours as indi-
cated [28]. Free fatty acids (FFA) (oleate/palmitate [PA], 2:1;
Kelong Chemical Reagent Factory, Chengdu, China) were
mixed with FFA-free bovine serum albumin, and the mix-
ture was added to the medium to a final concentration of
1 mmol/L [21]. Intracellular accumulation of lipid droplets
in 3T3-L1 preadipocytes were stained with Oil Red O
(0.5 g in 100 ml isopropanol) at the day 3, 5, and 8 with or
without differentiation.Intracellular free calcium measurement
3T3-L1 cells grown on glass cover slips were loaded with
Ca2+ indicator Fura-2 (2 μmol/L, Invitrogen, Paisley,
UK) and 0.025% Pluronic F-127 in a physiological saline
solution for 40 min at room temperature in the dark.
[Ca2+]i was measured using a fluorescent plate reader
(Varioskan Flash, Thermo) at 510 nm emission, with ex-
citation wavelengths of 340 nm and 380 nm. The
changes in [Ca2+]i were calculated from the ratios of
transient increases in fluorescence intensity at 340 nm
and 380 nm [8].Fluorescence Recovery after Photo bleaching (FRAP)
All fluorescent dyes emit light of one wave length (e.g.
green) after they have absorbed light of another wave
length (e.g. blue). However, if a very high intensity blue
light is delivered to the dye, the dye will “photobleach”
meaning that the high intensity light has rendered the
dye unable to fluoresce. This phenomenon has lead to
an interesting method called Fluorescence Recovery After
Photobleaching (FRAP). The idea behind this method is
to use FRAP to measure the ability of a molecule to move
around over time. The percent recovery uses the formula:
(Y/ X) × 100 = % recovery. In the diagram, the percentage
of fluorescence lost due to photo bleaching is X and the
amount of fluorescence that returned to the bleached area
is Y. FRAP evaluates the functional effect of gap junctions
for intercellular communication between adjacent cells by
dye coupling studies, in which photobleaching of cells
loaded with a membrane-permeable fluorescence dye,
5, 6-carboxyfluorescein diacetate (5, 6-CFDA, Invitrogen
Corp, Carlsbad, CA, USA), resulted in rapid recovery of
fluorescence into the photobleached cell, within 10 min
postbleaching [29,30]. After treatment, cells were rinsed
twice with 1 ml of Hank buffer and incubated with 5, 6-
CFDA (8 μg/mL in DMEM) at 37°C for 15 minutes, and
quantitative imaging was excited at 488 nm by an argon
ion laser and captured through a gating at 530/30 nm.
The analyzed fluorescence recovery index is expressed as:
R = (IR-I0)/(Ii-I0) × 100%. Fluorescence recovery was nor-
malized with unbleached control to compensate fluores-
cence lost during the experiment [31].
Immunoblotting analysis
Immunoblotting of TRPV1, Cx43, p-CaM, CaMKII,
PPARδ, HSL, β-actin and GAPDH were performed using
standard techniques for adipose tissue and mature adipose
cells. Primary antibody for TRPV1 was purchased from
Alomone, Israel and other primary antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). After
incubation with the secondary antibodies for 1 h, the pro-
teins were detected by enhanced chemiluminescence and
quantified using a Gel Doc 2000 Imager (Bio-Rad).
Measurement of triglyceride and free fatty acid in cells
Total lipids were extracted from 3T3-L1 preadipocytes
using a chloroform-methanol (2:1, vol/vol) mixture. Tri-
glyceride and free fatty acid levels were quantified using
ELISA kit (Applygen Technologies Inc., China) accord-
ing to the manufacturer’s instructions. Cell extracts were
collected and centrifuged at the speed of 10000 rpm for
15 min to obtain the supernatant. Then 100 μl super-
natant and 50 μl enzyme conjugate were added to the
provided 96-well plate for 1 h in 37°C while standard
curve was made in the same plate. Afterwards, each well
was washed with the diluted washing solution for 5
Figure 1 (See legend on next page.)
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Figure 1 Cx43 affects TRPV1-mediated Ca2+ influx in adipocytes. A. TRPV1 and Cx43 were detected in mesenteric adipose tissue (Vis) and
3T3-L1 preadipocytes (3T3-L1). M indicates the marker. B and C. Immunofluorescence demonstrated specific staining for co-expressed TRPV1 and
Cx43 in the cell-cell connecting portions in primary cultured human visceral adipocytes B and visceral adipose tissues from both wild-type mice
(WT) and humans C. The green fluorescence indicates Cx43. The red fluorescence indicates TRPV1. Nuclei in all groups were stained in blue with DAPI.
The images were collected using a Nikon TE2000-U inverted fluorescence microscope and are representative of 3 separate experiments. The scale bar
indicates 25 μm. D. Representative curves (left panel) show [Ca2+]i changes in 3T3-L1 preadipocytes acutely stimulated with capsaicin (Cap, 1 μmol/L),
capsaicin with the TRPV1 antagonist capsazepine (Cap + Capz, 1 μmol/L), the Cx43 inhibitor, 18α-glycyrrhetinic acid (Cap + 18α-GA, 100 or 150 μmol/L),
or the intracellular Ca2+ chelator, BAPTA-AM (10 μmol/L). The summary data (right panel) show the maximal stimulated changes of [Ca2+]i (25-150 s)
from the baseline (0-25 s). Values were expressed as the mean ± SEM; n = 4 per group. **P < 0.01 vs. Cap; ##P < 0.01 vs. Cap + Capz; ΔP < 0.05, ΔΔP < 0.01
vs. Cap + 18α-GA 100 μM.
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50 μl substrate A and 50 μl substrate B were successively
added and the plate was incubated in 37°C for 15 min.
At last, stop solution 50 μl was then added to each well
and the OD450 values were measured with the Varios-
kan Flash, Thermo.
Statistical analysis
The data were expressed as the means ± SEM from three
to 3-15 independent experiments or mice. Comparisons
between groups were analyzed using the Student’s t test
or one-way ANOVA with Bonferroni’s multiple compari-
son post hoc test (GraphPad Prism; La Jolla, CA, USA).
Two-tailed p values less than 0.05 were considered to
indicate statistical significance.
Results
Functional TRPV1 co-expressed with Cx43 in mesenteric
adipose tissues and 3T3-L1 preadipocytes
First, we detected TRPV1 and Cx43 in visceral adipose
tissues from mice and 3T3-L1 preadipocytes by immuno-
blotting. The immunoblots confirmed the TRPV1 and
Cx43 molecular weights at 95 kDa and 43 kDa, respect-
ively, and the antibodies identified TRPV1 and Cx43 in
both mesenteric adipose tissues and 3T3-L1 preadipocytes
(Figure 1A). Immunofluorescence demonstrated specific
staining for co-expressed TRPV1 and Cx43 in the cell-cell
connecting portions in primary cultured human visceral
adipocytes and visceral adipose tissues from both wild-
type mice (WT) and humans. The green fluorescence in-
dicates Cx43. The red fluorescence indicates TRPV1. Nu-
clei in all groups were stained in blue with DAPI
(Figure 1B and C). Cx43 is a gap junction protein, and
18α-GA is the gap-junction inhibitor widely used to in-
hibit gap junctional communication that is likely to enter
cells and modify protein kinases that regulate Cx43 [32].
Capsazepine is a TRPV1 antagonist [33]. TRPV1 belongs
to the family of nonselective cation channels that display
high Ca2+ permeability. Acute exposure to capsaicin, a
TRPV1-specific agonist, stimulated an increase in the
cytosolic free calcium concentration ([Ca2+]i) in cultured
3T3-L1 preadipocytes. According to a previous study, cal-
cium ions are most likely to travel through GJs, and thedifferential Ca2+ uptake into intracellular stores at high
and low concentrations is influenced by slight time delays
of Ca2+ traveling through the GJs. TRPV1-elicited Cx43
gap-junction assay showed that response of Ca2+ to capsa-
icin was completely inhibited by 150 μM 18α-GA in
Cx43-expressing HeLa cells [34]. We found that the
capsaicin-induced calcium increase could be inhibited by
18α-GA at a concentration of 100 μmol/L, whereas the
maximum effect was obtained at 150 μmol/L in 3T3-L1
preadipocytes. We also showed that 18α-GA dose-
dependently inhibited calcium influx by capsaicin-induced
activation of TRPV1, and that 18α-GA (150 μM) could
completely block the increased calcium influx by cap-
saicin, as capsazepine effect in 3T3-L1 preadipocytes
(Figure 1D). These results suggest that functional TRPV1
and Cx43 exist in adipose tissues and cells, both in
humans and mice. Inhibition of TRPV1 and Cx43 re-
duces the increased free cytosolic calcium concentra-
tion ([Ca2+]i) in 3T3-L1 preadipocytes.
Inhibition of Cx43 reduces the cytosolic calcium increase
induced by TRPV1 activation and prevents adipolysis in
3 T3–L1 preadipocytes
Our previous study showes that the administration of
capsaicin prevents obesity in male WT mice but not in
TRPV1−/− mice fed a high-fat diet [20]. In the present
study, we found that dietary capsaicin also reduced the
weights of perirenal, mesenteric and testicular adipose
tissues in WT mice but not TRPV1−/− mice fed a high-
fat diet (Figure 2A). Based on the previous findings by
Zhang et al., TRPV1 activation by capsaicin increases
intracellular calcium concentrations and prevents adipo-
genesis in 3T3-L1 preadipocytes. We evaluated the
effects of Cx43 on lipid deposition which regulated by
TRPV1 in 3T3-L1 preadipocytes. Adipogenesis was
induced in 3T3-L1 preadipocytes, as described in our
previous study [20]. Lipid droplets were visualized by
Oil red O-staining in 3 T3–L1 preadipocytes on days 3,
5, and 8, with or without differentiation, in the absence
(control condition) and presence of capsaicin (TRPV1
agonist), capsaicin plus 18α-GA (Cx43 gap-junction
inhibitor), or capsazepine (TRPV1 antagonist) [24,25].
Maturation of the 3T3-L1 preadipocytes was induced by
Figure 2 (See legend on next page.)
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Figure 2 TRPV1 activation promotes lipolysis both in mesenteric adipose tissue and 3T3-L1 preadipocytes. A. The weights of mesenteric,
perirenal and testicular adipose tissues from WT and TRPV1−/− mice fed a normal diet (ND), a high-fat diet (HD), or a high-fat plus capsaicin diet
(HC). *P < 0.05 vs. ND, #P < 0.05 vs. HD. Values are expressed as the mean ± SEM, n = 6. B. Lipid droplets were visualized by Oil red O staining of
3T3-L1 preadipocytes on days 3, 5, and 8, with or without differentiation. The cells were exposed to a mixture of 1 mmol/L long-chain free fatty
acids (FFA) in the presence of 1 μmol/L capsaicin (FFA + Cap), capsaicin plus 1 μmol/L capsazepine (FFA + Cap + Capz) or 150 μmol/L 18α-GA
(FFA + Cap + 18α-GA) for 24 h. Red spots indicate lipid droplets in the cells. Images are representative of 3 separate experiments. The scale bar
indicates 10 μm. C and D. Triglyceride and free fatty acid levels of 3T3-L1 preadipocytes after treatment with free fatty acids (FFA), FFA + capsaicin
(Cap), FFA + capsaicin + capsazepine (Capz) or FFA + capsaicin + 18α-GA (18α-GA, 150 μmol/L) for 24 h. *P < 0.05 vs Con, #P < 0.05 vs FFA, ΔP < 0.05 vs
Cap. Values are expressed as the mean ± SEM; n = 3 per group.
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as recommended. Free fatty acids (FFAs) increased the
number of lipid droplets after maturation was induced.
Capsaicin, the TRPV1 agonist (final concentration,
1 μmol/L), reduced the amount of lipid droplets in
3T3-L1 preadipocytes. Furthermore, determination of
cellular triglyceride levels confirmed that capsaicin
prevented adipogenesis, whereas the administration of
capsazepine or 18α-GA did not prevent adipogenesis in
3T3-L1 preadipocytes. The maximum effect of 18α-GA
was obtained at a concentration of 150 μmol/L in 3T3-
L1 preadipocytes (Figure 2B). We found that capsaicin
induced an increase in the intracellular calcium levels
and a decrease in triglyceride levels, which could be
inhibited by capsazepine, a TRPV1 antagonist, at a con-
centration of 1 μmol/L, or 18α-GA, a Cx43 gap-junction
inhibitor, at a concentration of 100 μmol/L; however, the
maximum effect of 18α-GA was obtained at 150 μmol/L
in 3T3-L1 preadipocytes. The accumulations of triglycer-
ide and free fatty acids did not significantly differ between
FFA, FFA + Cap plus Capz and FFA +Cap plus 18α-GA
groups (Figure 2C and D). Thus, we found that the admin-
istration of FFAs significantly increased the intracellular
lipid droplets in 3T3-L1 preadipocytes, whereas capsaicin
led to reduced intracellular lipid droplets. In contrast, the
antagonism of TRPV1 or the inhibition of Cx43 abolished
the effect of capsaicin on the adipolysis of preadipocytes.
Based on these experiments, it was concluded that the
capsaicin-induced cytosolic calcium increase through
TRPV1 channels promoted adipolysis associated with
Cx43-mediated Ca2+ influx.
TRPV1 promotes lipolysis of 3T3-L1 preadipocytes by
regulating Cx43-mediated intracellular calcium levels
Fluorescence Recovery After Photobleaching is used to
measure the dynamics of Cx43 mobility. We used the
gap-FRAP method to study the effect of TRPV1 on
Cx43 in 3T3-L1 preadipocytes. The results showed that
the inhibition of both TRPV1 and Cx43 induced few
changes outside and little recovery of fluorescence inside
the bleached regions in 3T3-L1 preadipocytes treated
with both Capsazepine and 18α-GA, which damaged the
dynamics of Cx43 mobility (Figure 3A and B). The 3T3-
L1 preadipocytes were treated with free fatty acids(FFA), FFA + capsaicin (Cap), FFA + capsaicin plus TRPV1
antagonist capsazepine (Capz), FFA + capsaicin + ethylene-
glycol-bis (beta-aminoethylether)-N, N’-tetraacetic acid
(EGTA, calcium chelator), FFA + capsaicin + 18α-GA
(18α-GA, 150 μmol/L) or FFA + capsaicin plus PPARδ
inhibitor GSK0660 (10 μmol/L) for 24 h. The drug
intervention showed that TRPV1 activation by capsa-
icin led to the up-regulation of Cx43, CaMKII, PPARδ
and HSL. Inhibition of TRPV1 or Cx43 by capsazepine
or 18α-GA and exposure to EGTA mediated the down-
regulation of Cx43, CaMKII, PPARδ and HSL in 3T3-
L1 preadipocytes (Figure 3C). These results indicated
that TRPV1 activation by capsaicin increased intracellular
calcium associated with Cx43 function and promoted
lipolysis in 3T3-L1 preadipocytes.
TRPV1 activation by capsaicin increases Cx43 mediated
lipolysis of visceral adipose tissue in humans and mice
We further studied the effects of chronic dietary capsaicin
on p-CaM, Cx43, CaMKII, PPARδ and HSL in visceral
adipose tissue from WT mice or TRPV1−/− mice fed a
high-fat diet and mesenteric adipose tissue from obese
or lean human male subjects. The results showed that,
compared with a normal diet, a long-term high-fat diet
significantly reduced the protein expression levels of p-
CaM, Cx43, CaMKII, PPARδ and HSL in mesenteric
adipose tissues from WT mice, but that these effects
were reversed by chronic dietary capsaicin. In contrast,
the effects of dietary capsaicin on the up-regulation of
p-CaM, Cx43, CaMKII, PPARδ and HSL in visceral adi-
pose tissue were absent in TRPV1−/− mice fed a high-fat
diet plus capsaicin (Figure 4A). Furthermore, we also con-
firmed that the expression levels of TRPV1, p-CaM, Cx43,
CaMKII, PPARδ and HSL in mesenteric adipose tissue
from obese human male subjects were significantly de-
creased compared with age-matched lean male subjects.
The protein expression levels of TRPV1, p-CaM, Cx43,
CaMKII, PPARδ and HSL were significantly decreased in
the mesenteric adipose tissue from obese male subjects,
but were reversed after the adipose tissue was treated with
capsaicin for 24 h (Figure 4B). The expression levels of
TRPV1, p-CaM, Cx43, CaMKII, PPARδ and HSL in mes-
enteric adipose tissue from db/db mice were decreased
compared with those from WT mice fed a normal diet
Figure 3 (See legend on next page.)
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Figure 3 TRPV1 promotes lipolysis of 3T3-L1 preadipocytes through the regulation of Cx43-mediated intracellular calcium levels.
A. Images indicate the Fluorescence Recovery After Photobleaching (FRAP), after treatment with capsaicin (Cap), capsaicin + capsazepine (Capz) or
capsaicin + 18α-GA (18α-GA) for 24 h, used to measure the dynamics of Cx43 mobility. B The ratio of fluorescence recovery inside the bleached
regions. *P < 0.05 vs Con, #P < 0.05 vs Cap. The values were expressed as the mean ± SEM from 3 separate experiments. C. Immunoblots of TRPV1,
p-CaM, Cx43, CaMKII, PPARδ, and HSL in 3T3-L1 preadipocytes treated with free fatty acids (FFA), FFA + capsaicin (Cap), FFA + capsaicin + capsazepine
(Capz), FFA + capsaicin + EGTA (EGTA), FFA + capsaicin + 18α-GA (18α-GA) or FFA + capsaicin + GSK0660 (GSK0660, PPARδ inhibitor, 10 μmol/L) for
24 h. *P < 0.05, **P < 0.01 vs Con; #P < 0.05, ##P < 0.01vs FFA; ΔP < 0.05, ΔΔP < 0.01 vs Cap. The densitometric values of protein expression levels were all
normalized to GAPDH. Values are expressed as the mean ± SEM; n = 3 per group.
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increased the expression levels of TRPV1, p-CaM, Cx43,
CaMKII, PPARδ and HSL in visceral adipose tissue
from db/db mice compared with db/db ND group mice
(Figure 4B). These results further confirm that TRPV1
activation by chronic capsaicin up-regulates p-CaM,
Cx43, CaMKII, PPARδ and HSL in visceral adipose tis-
sues from both humans and mice.
TRPV1 activation by dietary capsaicin improves high-fat
diet-induced obesity and lipid metabolism
The body weights of WT and TRPV1-/- mice fed a high-
fat diet (HD) were significantly higher than those of the
ND group mice after a 2-month intervention. Because
chronic activation of TRPV1 by dietary capsaicin pro-
moted lipolysis of visceral fat, we sought to determine
whether TRPV1 activation by capsaicin reduced the body
weight, food intake, serum TG, total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C) and high-
density lipoprotein cholesterol (HDL-C). We found that
chronic dietary capsaicin significantly reduced the body
weights of WT mice fed a high-fat diet after 5 months,
but that the effect was absent in TRPV1-/- mice (Figure 5A
and B). The food intake was no difference between each
group both in WT and TRPV1-/- mice. Dietary capsaicin
also lowered serum lipid levels in WT mice fed a high-fat
diet (Table 1). Thus, long-term dietary capsaicin lowers
the body weight and serum lipid levels in mice fed a high-
fat diet.
Discussion
In this study, we found that functional TRPV1 co-
expressed with Cx43 in both visceral adipose tissue and
3T3-L1 preadipocytes. TRPV1 activation by capsaicin
increased intracellular calcium levels, affected the func-
tion of Cx43, and further promoted lipolysis in 3T3-L1
preadipocytes. Long-term chronic capsaicin increased
the expression of p-CaM, Cx43, CaMKII, PPARδ and
HSL in visceral adipose tissues from WT and db/db mice
and obese humans. These results suggest that long-term
dietary capsaicin promotes visceral fat remodeling and
prevents high-fat-diet-induced obesity in mice by in-
creasing the Ca2+ influx through the TRPV1 channels
mediated by Cx43.Capsaicin is the major pungent ingredient in chili pep-
pers and is a highly selective agonist for the TRPV1
channels expressed in sensory neurons and adipose tis-
sues [8,9]. TRPV1 is a non-selective cation channel that
is permeable to Na+, Ca2+ and Mg2+ and mediates trans-
membrane cation flow after stimulated activation. TRPV1
is activated via phosphorylation by protein kinases, the
calcium and calmodulin- dependent protein kinase II
(CaMKII kinase) and cleavage of phosphatidylinositol 4,
5-bisphosphate (PIP2) by phospholipase C [35]. The N-
terminus of TRPV1 has several phosphorylation sites for
protein kinases which aid in its activation whereas TRPV1
desensitization results from its dephosphorylation by
phosphatises [36]. Capsaicin activates TRPV1 resulting
from extracellular calcium dependent conformational
changes in the receptor protein, ultimately closing the
channel pore. Extracellular calcium influx triggers the
release of the intracellular calcium pool and enhances
the intracellular free calcium concentration [37]. The
movement of calcium ions through the cell membrane
into the cell is considered a marker of the intracellular
signaling pathway, and a series of basic activities affect-
ing cellular energy metabolism is initiated. Intracellular
calcium ions are considered important molecules in
hypertension, insulin resistance, and obesity. Our previ-
ous study has shown that chronic activation of endo-
thelial TRPV1 channel, which mediates an increased
Ca2+ influx and subsequent phosphorylation of PKA
and eNOS. TRPV1 activation by capsaicin might
protect against hyperglycemia-induced endothelial dys-
function through a mechanism involving the PKA/
UCP2 pathway [38].
Moreover, a high-calcium diet can reduce lipid accu-
mulation and promote lipolysis and weight loss [39]. In
the early stages of adipocyte differentiation, increasing
intracellular free calcium levels can prevent adipocyte
differentiation and maturation [40]. Intracellular Ca2+ is
one of the important signaling molecules of adipogenesis.
Our previous studies showed that activation of TRPV1 by
dietary capsaicin prevents obesity by inhibiting adipocyte
differentiation and maturation with an increase in the in-
duction of Ca2+ influx [20]. Therefore, intracellular free
calcium regulates lipid metabolism and is related to adipo-
cyte differentiation.
Figure 4 (See legend on next page.)
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Figure 4 TRPV1 activation by dietary capsaicin increases Cx43-mediated lipolysis of mesenteric adipose tissues in mice and humans.
A. Immunoblots of TRPV1, p-CaM, Cx43, CaMKII, PPARδ, and HSL in mesenteric adipose tissues from WT and TRPV1-/- mice fed a ND, HD and HC.
*P < 0.05 vs. WT ND, ##P < 0.01 vs. WT HD, ΔP < 0.05 vs. TRPV1-/- ND. B. Immunoblots of TRPV1, p-CaM, Cx43, CaMKII, PPARδ, and HSL in visceral
adipose tissues from humans and WT and db/db mice. Obese + Cap indicates that visceral adipose tissues from obese humans were treated with
capsaicin for 24 hours. Db/db mice were fed a standard laboratory chow (db/db ND) or standard laboratory chow plus 0.01% capsaicin (db/db
NC). *P < 0.05 vs lean people, #P < 0.05 vs obese people, ΔP < 0.05 vs WT, ▲P < 0.05 vs db/db ND. The densitometric values of protein expression
levels were all normalized to GAPDH or β-actin. Values are expressed as the mean ± SEM for 3 mice or people.
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calcium channels. Connexin is a direct channel regularly
present between cells that regulates signal transduction,
ions, amino acids, nucleotides, second messengers and
other metabolic factors; it allows the passage of mole-
cules with molecular weights less than 1000 Da [41].
Calmodulin (CaM), a cytosolic Ca2+ binding protein, is a
single-chain acidic protein with a weight of 16700 Da.
CaM has four regions with similar structures that can be
combined with calcium ions per molecule. When the
intracellular calcium concentration transiently increases
to 10 ~ 100 times the extracellular calcium concentra-
tion, CaM is activated after binding to calcium ions and
then combines with enzymes. The intracellular calcium
concentration, regulated by calcium ions, is importantFigure 5 TRPV1 activation by dietary capsaicin improves high-fat diet
WT A and TRPV1−/− B mice fed with ND, HD and HC. The values are expre
##P < 0.01 vs. HD.for biochemical reactions. CaM is proposed to play a
role in the Ca2+-induced uncoupling of gap junctions
because CaM inhibitors were shown to prevent this re-
sponse [42]. CaM binding sites were recently identified
in the cytoplasmic loops of at least three α-subfamily
connexins (Cx43, Cx44, and Cx50).
Cx43 gap junctions are gated by a Ca2+/CaM-
dependent mechanism involving the carboxyl-terminal
quarter of the connexin cytoplasmic loop domain [43].
The amino acid residues in the Cx43- carboxyl terminus
are targets of multifunctional protein kinases such as
Ca2+/CaM protein kinase II (CaMKII), an enzyme known
to play critical roles in Ca2+ homeostasis, transcription,
apoptosis, and ischemic heart disease. The activity of
CaMKII is important for regulating Cx43 in normal and-induced obesity. A and B. Body weight gain and food intake of
ssed as the mean ± SEM for 15 mice. *P < 0.05, **P < 0.01 vs. ND,
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the differentiation and proliferation of adipocytes. The
inhibition of Cx43 expression and function induces
osteoblast trans-differentiation into adipocytes and allows
muscle cells to differentiate into adipocytes [45]. Further-
more, the inhibition of gap junctions promotes osteoblast
cell differentiation into adipocytes and the expression of
lipoprotein lipase and PPARγ2, resulting in lipid droplet
accumulation [46]. In the process of 3T3-L1 preadipocyte
differentiation, the connexin inhibitor, 18α-GA, or Cx43
RNA interference inhibits 3T3-L1 cell differentiation
and reduces the expression levels of PPARγ2 and
GLUT4 in mature adipocytes [23]. Therefore, gap junc-
tions play important roles in adipocyte differentiation
and lipid deposition.
Our results showed that the activation of a TRPV1-
induced calcium influx was reduced in the case of Cx43
inhibition. Previous studies showed that the Ca2+ status
between cells is affected by adjusting the gap junction
[47]; connexin expression affects the transmission of in-
formation between cells, including the transfer of Ca2+
[48]. Calcium influx and calcium ion permeability are
closely related given that Ca2+-dependent ATP inhibitors
reduce the transient influx of Ca2+. Others found that in
neonatal rat cultured myocytes, dominant-negative (DN)
inhibition of Cx43 impaired intercellular coupling and
desynchronized Ca2+ transients among individual cells
[49]. The status of gap junction channels is related to the
intracellular pH value, ionic changes, cAMP inhibition, Cx
protein phosphorylation and genetic factors. The level of
intracellular Ca2+ is one of the important factors that
affect the permeability of connexin expression. The intra-
cellular Ca2+ concentration influences connexin function
[50], and intracellular calcium overload in ventricular
myocytes affects the coupling function between cells [51].
Thus, Cx43 activity is affected by intracellular free Ca2+
and regulates intracellular calcium levels.
Peroxisome proliferator activated receptor (PPAR) δ
and hormone sensitive lipase (HSL) play critical roles in
energy balance, including TG metabolism, fatty acid hand-
ling and storage, and glucose homeostasis; the dysregula-
tion of these processes characterizes obesity, diabetes, and
atherosclerosis. PPARs are ligand-activated nuclear recep-
tors that are involved in the transcriptional regulation ofTable 1 Biochemical characteristics of WT and TRPV1−/− mice
WT mice
ND(n = 15) HD(n = 15) HC(n
TG (mmol/l) 0.71 ± 0.04 1.04 ± 0.10** 0.70
TC (mmol/l) 2.10 ± 0.15 3.16 ± 0.19** 2.76
LDL-C (mmol/l) 0.84 ± 0.07 1.14 ± 0.04** 0.97
HDL-C (mmol/l) 0.81 ± 0.09 0.85 ± 0.09 0.65
Data are mean ± SEM for 15 mice. *P < 0.05, **P < 0.01 vs. WT ND, #P < 0.05 vs. WT Henergy balance and inflammation. Nutrients such as fatty
acids direct cellular biology by inducing specific transcrip-
tional responses in the nucleus. PPARs are involved in a
mechanism through which nutrient-driven transcriptional
regulation can occur [52]. Recent studies suggest that
PPARδ regulates lipid metabolism in adipocytes both
in vitro and in vivo. PPARδ therapies have complementary
effects in improving lipoprotein subfractions associated
with atherogenic dyslipidemia [53]. Pharmacological acti-
vation of PPARδ inhibited lipogenesis in high-fat diet-
induced diabetic mice [54]. The release of free fatty acids
from fat stores requires the enzymatic activity of lipases.
Mobilization of fatty acids from TG stores in adipose
tissue requires lipolytic enzymes. HSL is the only rate-
limiting enzyme in the lipolysis of TG stored in adipo-
cytes, and the classical lipolytic PKA/HSL pathway is
activated by isoproterenol, forskolin and IBMX [55].
Genetic activation of HSL in mice decreases the adipose
mass and leads to triacylglycerol deposition in multiple
tissues. A high-fat diet induces the suppression of HSL
and AMPK signaling in lipolysis and the utilization of
lipids in visceral and subcutaneous adipocytes, which may
play an important role in the defective lipid mobilization
and metabolism observed in diet-induced obesity [56].
HSL participates in lipolysis through fatty acid β-oxidation
[57], while PPARδ activation can increase the levels of
HSL and CPT1 in adipose tissue [58]. Our previous study
also showed that chronic dietary capsaicin promotes the
lipolysis of fatty liver by up-regulating HSL and PPARδ in
WT mice [21]. The present study showed that TRPV1 ac-
tivation increased the expression levels of Cx43, p-CaM
and CaMKII through an increased intracellular free cal-
cium concentration and triggered a series of physiological
cellular activities. The up-regulation of p-CaM and CaM-
KII activated PPARδ and HSL and promoted lipolysis.
Our previous studies showed that capsaicin activates
TRPV1 and promotes extracellular Ca2+ influx [41,59],
whereas the present study showed that TRPV1 activa-
tion enhances the function of gap junctions, increases
extracellular Ca2+ influx and activates Cx43. Therefore,
we showed that TRPV1 activation induces an influx of
calcium mediated by Cx43, and furthermore that Cx43
influenced intracellular Ca2+ levels to promote lipolysis
and visceral fat remodeling.TRPV1-/- mice
= 15) ND(n = 15) HD(n = 15) HC(n = 15)
± 0.04# 0.68 ± 0.13 0.91 ± 0.06* 0.87 ± 0.07*
± 0.48# 1.97 ± 0.21 2.46 ± 0.15* 2.26 ± 0.18*
± 0.03# 0.86 ± 0.11 1.01 ± 0.05* 0.97 ± 0.02*
± 0.18 0.79 ± 0.38 0.80 ± 0.10 0.82 ± 0.11
D.
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In conclusion, we provided new evidence that TRPV1
activation by dietary capsaicin promotes visceral fat
remodeling through the up-regulation of Cx43, which
may represent a novel strategy for the management of
obesity. Thus, dietary capsaicin may represent a promis-
ing lifestyle intervention in populations that are at high
risk for obesity.
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